These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Oral administration of factor VIII or IX concentrate preparation]. Sakuragawa N Rinsho Ketsueki; 1985 Jul; 26(7):1086-9. PubMed ID: 3932721 [No Abstract] [Full Text] [Related]
24. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease. Brinkhous KM Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773 [TBL] [Abstract][Full Text] [Related]
26. [Structure and function of clotting factor VIII: the results of fundamental research]. Beck EA; Furlan M Ther Umsch; 1979 Apr; 36(4):294-300. PubMed ID: 377554 [No Abstract] [Full Text] [Related]
27. Immunologic studies in von Willebrand's disease: alteration of factor VIII/von Willebrand protein after transfusion with plasma concentrates in patients with von Willebrand's disease. Sultan Y; Simeon J; Maisonneuve P; Caen JP Thromb Haemost; 1976 Feb; 35(1):110-9. PubMed ID: 1085498 [TBL] [Abstract][Full Text] [Related]
28. The diagnosis of von Willebrand's disease. Bowie EJ; Owen CA Ann Clin Lab Sci (1971); 1971; 1(1):85-91. PubMed ID: 4949765 [No Abstract] [Full Text] [Related]
29. Von Willebrand factor, factor VIII and the factor VIII/von Willebrand factor complex. Ingerslev J Dan Med Bull; 1990 Oct; 37(5):385-406. PubMed ID: 2125548 [No Abstract] [Full Text] [Related]
30. The factor VIII complex: structure and function. Hoyer LW Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681 [TBL] [Abstract][Full Text] [Related]
31. Transplantation of the spleen: experimental cure of hemophilia. Norman JC; Covelli VH; Sise HS Surgery; 1968 Jul; 64(1):1-14. PubMed ID: 4173158 [No Abstract] [Full Text] [Related]
32. Treatment of single factor deficiencies: a case study approach. Marques MB Clin Lab Sci; 2003; 16(2):120-2. PubMed ID: 12757193 [No Abstract] [Full Text] [Related]
33. Transfusion therapy in congenital coagulopathies. Lusher JM Hematol Oncol Clin North Am; 1994 Dec; 8(6):1167-80. PubMed ID: 7860443 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and control of antihemophilic globulin (plasma factor 8). Zukoski CF; Hutchin P; Webster WP; Penick G Surg Forum; 1970; 21():370-1. PubMed ID: 4936991 [No Abstract] [Full Text] [Related]
35. Therapy of hereditary disorders of blood coagulation. Breckenridge RT; Ratnoff OD Mod Treat; 1968 Jan; 5(1):39-60. PubMed ID: 4870179 [No Abstract] [Full Text] [Related]
37. Further studies of in vivo complementation in hemophilia. Graham JB; Barrow EM; Heindel CC; Roberts HR Thromb Diath Haemorrh Suppl; 1966; 20():279-82. PubMed ID: 5298377 [No Abstract] [Full Text] [Related]
38. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease]. Fukui H; Takase T Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720 [No Abstract] [Full Text] [Related]
39. [Action of anti-factor VIII antibodies on platelet adherence to glass beads]. Mazurier C; Parquet-Gernez A; Goudemand M Pathol Biol (Paris); 1973 Nov; 21():Suppl:72-5. PubMed ID: 4587020 [No Abstract] [Full Text] [Related]
40. Hemophilia and von Willebrand's disease: genetic considerations. Green D Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]